Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
5.50
-0.49 (-8.18%)
Aug 18, 2026, 4:00 PM EST

Silence Therapeutics Statistics

Total Valuation

SLNCF has a market cap or net worth of 848.95 million. The enterprise value is 777.01 million.

Market Cap848.95M
Enterprise Value 777.01M

Important Dates

The next estimated earnings date is Tuesday, November 10, 2026.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 180.63M
Shares Outstanding n/a
Shares Change (YoY) +0.09%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 44.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1,380.41
PB Ratio 22.07
P/TBV Ratio 30.42
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.42, with a Debt / Equity ratio of 0.00.

Current Ratio 7.42
Quick Ratio 6.40
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF -0.00
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -90.41% and return on invested capital (ROIC) is -60.67%.

Return on Equity (ROE) -90.41%
Return on Assets (ROA) -29.65%
Return on Invested Capital (ROIC) -60.67%
Return on Capital Employed (ROCE) -68.76%
Weighted Average Cost of Capital (WACC) 12.01%
Revenue Per Employee 6,989
Profits Per Employee -681,284
Employee Count88
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

In the past 12 months, SLNCF has paid 2,000 in taxes.

Income Tax 2,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +226.41% in the last 52 weeks. The beta is 1.41, so SLNCF's price volatility has been higher than the market average.

Beta (5Y) 1.41
52-Week Price Change +226.41%
50-Day Moving Average 1.88
200-Day Moving Average 4.65
Relative Strength Index (RSI) 68.74
Average Volume (20 Days) 1,872

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.02

Income Statement

In the last 12 months, SLNCF had revenue of 615,000 and -59.95 million in losses. Loss per share was -1.27.

Revenue615,000
Gross Profit 528,000
Operating Income -64.43M
Pretax Income -59.95M
Net Income -59.95M
EBITDA -63.94M
EBIT -64.43M
Loss Per Share -1.27
Full Income Statement

Balance Sheet

The company has 72.05 million in cash and 112,000 in debt, with a net cash position of 71.94 million.

Cash & Cash Equivalents 72.05M
Total Debt 112,000
Net Cash 71.94M
Net Cash Per Share n/a
Equity (Book Value) 38.47M
Book Value Per Share 0.81
Working Capital 81.57M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -42.26 million and capital expenditures -3,000, giving a free cash flow of -42.27 million.

Operating Cash Flow -42.26M
Capital Expenditures -3,000
Depreciation & Amortization 483,000
Net Borrowing n/a
Free Cash Flow -42.27M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 85.85%
Operating Margin -10,475.61%
Pretax Margin -9,748.13%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SLNCF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.09%
Shareholder Yield -0.09%
Earnings Yield -7.06%
FCF Yield -4.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SLNCF has an Altman Z-Score of -6.32 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.32
Piotroski F-Score 2